title: Whipple's disease diagnosis following the use of TNF-α blockade.
authors.affiliation: Department of Rheumatology, Immunology and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. jasminegaddy@yahoo.com
authors.forename: Jasmine R
authors.initials: JR
authors.lastname: Gaddy
authors.forename: Zartash Z
authors.initials: ZZ
authors.lastname: Khan
authors.forename: Brad
authors.initials: B
authors.lastname: Chaser
authors.forename: R Hal
authors.initials: RH
authors.lastname: Scofield
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D008061:Whipple Disease / Q000175:diagnosis*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab